Health & Biotech
Check out the latest Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
News
Rise and Shine: What you need to know before the ASX opens
News
Aussie regulator raps cannabis companies over their reggie weed
Health & Biotech
Health Kick Podcast: Investors still high on Incannex cannabinoid pivot and COVID-19 treatment news
Health & Biotech
Creso Pharma’s Canadian subsidiary receives $189,000 recreational cannabis order
Health & Biotech
MGC Pharma fast-tracks London Stock Exchange listing
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Aussie cannabis industry set for painful shakeup – report
Health & Biotech
Weed Week: Good news from the TGA, but Australia’s CBD industry still lags the global pack
Health & Biotech
THC Global defends financials, existence
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Another pot stock is getting into the cannabis-based PPE trend
Health & Biotech
The ASX pot stocks looking to get high on Canada’s $3bn market
Health & Biotech
Pot Stocks: Althea tops the podium after becoming a licensed producer
Experts
ScoPo’s health powerplays: Pot stocks get a boost
Health & Biotech
Pot stocks look to launch new products following yesterday’s TGA ruling
Health & Biotech
North American fund backs MGC Pharmaceuticals to the tune of $15m
Health & Biotech
Creso Pharma sees ‘major opportunity’ after TGA interim decision
Health & Biotech
ASX pot stocks are getting high after TGA interim ruling
Health & Biotech
Shares in ECS Botanics jump on the back of landmark TGA announcement
Health & Biotech
Zelira Therapeutics to launch cannabis-based toothpaste
News
Elixinol Global looks to emerge from the ashes of cannabis collapse
Health & Biotech
Israeli Ministry of Health to test eSense-Lab compound for action against coronavirus
Health & Biotech
MGC Pharma strengthens leadership team with new appointments
Health & Biotech
MGC Pharma seals Russia joint venture for its medical products
Health & Biotech
MGC Pharma’s medical spray has success in COVID-19 clinical trial
Health & Biotech
Weed Week: Pot proves its worth in a pandemic as Aussie use rates climb
Health & Biotech
MGC Pharma secures UK distributor for its medicinal cannabis treatments
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Health & Biotech
ECS Botanics aims for first-mover advantage with landmark outdoor medicinal cannabis plan
Guides
Cannabis stocks guide: Here’s everything you need to know
Health & Biotech
Emerald Clinics breaks into UK medical cannabis market; shares surge 179pc
Stockhead TV
StockTalk: Australia’s medicinal cannabis sector is budding again
Health & Biotech
MGC Pharma’s medical spray could be effective COVID-19 treatment; shares spike +40pc
News
10 at 10: These ASX stocks have reached a milestone this morning
Health & Biotech
Here’s how Australia offers a strong operating environment for cannabis biotech stocks
Health & Biotech
Weed week: Cannabis researchers are still split on matters of the heart
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
Experts: How to position for the next wave in cannabis
Health & Biotech
Australia’s cannabis sector is finally maturing
Health & Biotech
CannPal’s doggie drug DermaCann tackles atopic dermatitis
Health & Biotech
MGC Pharma expands footprint with cannabis clinic acquisition
Health & Biotech
These are the ‘watershed’ reforms ASX cannabis investors should look out for
Health & Biotech
Pot stock Zelira Therapeutics successfully passes another Phase I clinical trial
Health & Biotech
Althea becomes first local cannabis player to launch online sales channel
Health & Biotech
Bod makes $2.5m from Aussie pot buyers in the June quarter alone
Health & Biotech
Creso Pharma streamlines Canada production ahead of launch
Load More
